Selected genetic polymorphisms and plasma coagulation factor VII changes with exercise training

Journal of Applied Physiology

Volumn 96, Issue 3, 2004, Pages 985-990

  Ghiu, Ioana A ^a   Ferrell, Robert E ^b   Kulaputana, Onanong ^a   Phares, Dana A ^a   Hagberg, James M ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genotype; Haplotype; Plasma lipoprotein lipids

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 7; LIPID; LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; ENDURANCE; EXERCISE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; SITTING;

AGED; ANALYSIS OF VARIANCE; EXERCISE; FACTOR VII; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 1342283022     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00877.2003     Document Type: Article

References (48)

1. Agren JJ, Valve R, Vidgren H, Laakso M, and Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 18: 1606-1610, 1998.
2. Ahn Y, Kamboh MI, Hamman RF, Cole SA, and Ferrell RE. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 34: 421-428, 1993.
3. Ahn YI, Hamman RF, Ferrell RE, and Kamboh MI. Association of lipoprotein lipase gene variation with the physiological components of the insulin-resistance syndrome in the population of the San Luis Valley, Colorado. Diabetes Care 16: 1502-1506, 1993.
4. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription (4th ed.). Philadelphia, PA: Lea & Febiger, 1991.
5. American Heart Association. Dietary guidelines for healthy American adults: a statement for physicians and health professionals by the nutrition committee. Circulation 77: 721A-724A, 1988.
6. Anderssen SA, Holme I, Urdal P, and Hjermann I. Associations between central obesity and indexes of hemostatic, carbohydrate and lipid metabolism. Results of a 1-year intervention from the Olso Diet and Exercise Study. Scand J Med Sci Sports 8: 109-115, 1998.
7. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, and Mariani G. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 16: 72-76, 1996.
8. Bladbjerg EM, Moller L, and Jespersen J. Association of factor VII protein concentration with lifestyle factors. Scand J Clin Lab Invest 58: 323-330, 1998.
9. Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, and Humphries SE. Interleukin-6 gene -17g>c and -57g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21: 1458-1463, 2001.
10. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, Jukema JW, Wijland M, VanDam M, Hudson TJ, Brooks-Wilson A, Genest J, Kastelein J, and Hayden MR. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103: 1198-1205, 2001.
11. Connelly JB, Cooper JA, and Meade TW. Strenuous exercise, plasma fibrinogen, and factor VII activity. Br Heart J 67: 351-354, 1992.
12. Dell'Acqua G, Iacoviello L, D'Orazio A, Di Bitondo R, Di Castelnuovo A, and Donati MB. A polymorphic cluster in the 5′ region of the human coagulation factor VII gene: detection, frequency, and linkage disequilibrium. Thromb Res 88: 445-448, 1997.
13. DeSousa C, Bruckert E, Giral P, Soria C, Chamman J, Truffert J, Dairou F, DeGennes JL, and Caen JP. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis 19: 125-130, 1989.
14. Di Castelnuovo A, D'Orazio A, Amore C, Falanga A, Donati MB, and Iacoviello L. The decanucleotide insertion/deletion polymorphism in the promoter region of the coagulation factor VII gene and the risk of familial myocardial infarction. Thromb Res 98: 9-17, 2000.
15. Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, and Stanton KG. A randomized, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics. Thromb Res 20: 593-600, 1999.
16. Feng D, Tofler GH, Larson MG, O'Donnell CJ, Lipinska I, Schmitz C, Sutherland PA, Johnstone MT, Muller JE, D'Agostino RB, Levy D, and Lindpainter K. Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: The Framingham Heart Study. Arterioscler Thromb Vasc Biol 123: 1230-1235, 2000.
17. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, and Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 91: 191-205, 1991.
18. Gallistl S, Sudi KM, Borkenstein M, Troebinger M, Weinhandl G, and Muntean W. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord 24: 1459-1464, 2000.
19. Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, Manzato F, Mazzucco A, Bernardi F, and Corrocher R. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 343: 774-780, 2000.
20. Green D, Chamberlain MA, Ruth KJ, Folsom AR, and Liu K. Factor VII, cholesterol, and triglycerides. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study. Arterioscler Thromb Vasc Biol 17: 51-55, 1997.
21. Hagberg JM, Ferrell RE, Katzel LI, Dengel DR, Sorkin JD, and Goldberg AP. Apolipoprotein E genotype and exercise training-induced increases in plasma HDL- and HDL2-cholesterol levels. Metabolism 48: 943-945, 1999.
22. Heinrich J, Balleisen L, Schulte H, Assmann G, and van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 14: 54-59, 1994.
23. Heywood DM, Carter AM, Catto AJ, Bamford JM, and Grant PJ. Polymorphisms of the factor VII gene and circulating FVII: C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 28: 816-821, 1997.
24. Hoffman CJ, Miller RH, and Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 12: 267-270, 1992.
25. Humphries S, Temple A, Lane A, Green F, Cooper J, and Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base pair promoter (0323) insertion than the glutamine 353 variant. Thromb Haemost 75: 567-572, 1996.
26. Humphries SE, Lane A, Dawson S, and Green FR. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1. Arch Pathol Lab Med 116: 1322-1329, 1992.
27. Iacoviello L and Donati MB. Blood coagulation factor VII activity and the risk of myocardial infarction: the novel identification of a genetic protection that can be mimicked by an old drug. G Ital Cardiol 28: 718-721, 1998.
28. Keonig W and Ernst E. Exercise and thrombosis. Coron Artery Dis 11: 123-127, 2000.
29. Mennen LI, deMaat MP, Meijer G, Zock P, Grobbee DE, Kok FJ, Kluft C, and Schouten EG. Postprandial response of activated factor VII in elderly women depends on the R353Q polymorphism. Am J Clin Nutr 70: 435-438, 1999.
30. Mennen LI, deMaat MP, Schouten EG, Kluft C, deJong PT, Hofman A, and Grobbee DE. Coagulation factor VII, serum-triglycerides and the R/Q353 polymorphism: differences between older men and women. Thromb Haemost 78: 984-986, 1997.
31. Mennen LI, deMaat MP, Schouten EG, Kluft C, Witteman JC, Hofman A, and Grobbee DE. Dietary effects on coagulation factor VII vary across genotypes of the R/Q353 polymorphism in elderly people. J Nutr 128: 870-874, 1998.
32. Miller GJ, Stirling Y, Howarth DJ, Cooper JC, Green FR, Lane A, and Humphries S. Dietary fat intake and plasma factor VII antigen concentration. Thromb Haemost 73: 893, 1995.
33. Miller S, Dykes D, and Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215-1218, 1988.
34. Moor E, Silveira A, van't Hooft F, Suontaka AM, Eriksson P, Blomback M, and Hamsten A. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol 15: 655-664, 1995.
35. Nordoy A, Bonaa KH, Sandset PM, Hansen JB, and Nilsen H. Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia. Nutr Metab Cardiovasc Dis 10: 15-23, 2000.
36. Oka K, Tkalcevic GT, Stocks J, Galton DJ, and Brown WV. Nucleotide sequence of PvuII polymorphic site at the human lipoprotein lipase gene locus. Nucleic Acids Res 17: 6752, 1989.
37. Pollak ES, Hung HL, Godin W, Overton GC, and High A. Functional characterization of the human factor VII 5′-flanking region. J Biol Chem 271: 1738-1747, 1996.
38. Saha N, Liu Y, Heng CK, Hong S, Low PS, and Tay JS. Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides. Arterioscler Thromb 14: 1923-1927, 1994.
39. Silveira A, Green F, Karpe F, Blomback M, Humphries S, and Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 72: 734-739, 1994.
40. Tamaki S, Iwai N, Nakamura Y, Tsujita Y, and Kinoshita M. Variation of the factor VII gene and ischemic heart disease in Japanese subjects. Coron Artery Dis 10: 601-606, 1999.
41. Tirindelli MC, Mariani G, Mazzucconi MG, Iacopino G, Carbonaro M, Ghirardini A, Motta M, and Mandelli F. Evaluation of factor VII antigen in factor VII congenital deficiencies with a new ELISA assay. Am J Hematol 26: 313-321, 1987.
42. van't Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Eriksson P, and Hamsten A. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood 93: 3432-3441, 1999.
43. Verissimo MT, Aragao A, Sousa A, Barbosa B, Palmeiro A, Antunes F, and Saldanha MH. Physical exercise and thrombotic risk in the elderly. Rev Port Cardiol 20: 625-639, 2001.
44. Wamala SP, Murray MA, Horsten M, Eriksson M, Schenck-Gustafsson K, Hamsten A, Silveira A, and Orth-Gomer K. Socioeconomic status and determinants of hemostatic function in healthy women. Arterioscler Thromb Vasc Biol 19: 485-492, 1999.
45. Wilund KR, Ferrell RE, Phares DA, Goldberg AP, and Hagberg JM. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism 51: 774-778, 2002.
46. Wosornu D, Allardyce W, Ballantyne D, and Tansey P. Influence of power and aerobic exercise training on haemostatic factors after coronary artery surgery. Br Heart J 68: 181-186, 1992.
47. Zambon A, Deeb SS, Hokanson JE, Brown BG, and Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 18: 1723-1729, 1998.
48. Zanettini R, Bettega D, Agostoni O, Ballestra B, del Rosso G, Di Michele R, and Mannucci PM. Exercise training in mild hypertension: effects on blood pressure, left ventricular mass and coagulation factor VII and fibrinogen. Cardiology 88: 468-473, 1997.